Hendrix Genetics and NPM Capital Join Forces in Animal Breeding and Life Sciences

Hendrix Genetics
Friday, 03 July 2015
By Hendrix Genetics
Hendrix Genetics and NPM Capitol signing the final agreement
Hendrix Genetics and NPM Capitol signing the final agreement Hendrix Genetics

July 1, 2015 - Hendrix Genetics and NPM Capital, a subsidiary of family-owned, SHV Holdings, have completed an agreement that will advance the animal breeding sector. Through the issue of new shares, NPM has become a 25 per cent minority shareholder in Hendrix Genetics, alongside existing shareholders. The Hendrix Family remains the majority and controlling shareholder.

Hendrix Genetics will continue to conduct its business under its current corporate governance and with its existing management team, strategy and structure. Its Vision 2020 plan, created last year, identified many opportunities to invest in R&D, capacity expansion and acquisitions to continue the company’s growth of the last decade. The equity of NPM/SHV will enable Hendrix Genetics to accelerate the execution of its ambitious plan.

Antoon van den Berg, CEO, Co-Shareholder and Co-Founder of Hendrix Genetics commented: “We are privileged as the Management Team of Hendrix Genetics, to have shareholders that fully support the accelerated execution of our ambitions. The fact that we continue to be family-controlled ensures passion and quick decision-making, which is essential to our company’s future.”

Jeroen Drost, CEO of NPM Capital, stated: “We discovered in Hendrix Genetics an ambitious company with dedicated shareholders, capable management and an excellent track-record in building a sound platform for industry consolidation. Their mission to help the world meet the growing demand for food, making animal protein production more efficient, affordable and sustainable perfectly fits our company ethos.”

International Advisory Board

Michel Boucly, member of the International Advisory Board since 2008, will step down per July 1, 2015 and will be succeeded by Cyril Melin, Investment Director of Sofiprotéol.

New member of the International Advisory Board, Investment Director of NPM Capital, Johan Terpstra sees clear benefits: “The strategic and cultural fit of Hendrix Genetics with NPM/SHV was clear from the onset and we look forward to partnering with existing shareholders and management to assist the growth of Hendrix Genetics in the years to come.”

Add comment


Security code
Refresh

Subscription Centre

 
New Subscription
 
Already a Subscriber
 
Customer Service
 
View Digital Magazine Renew

Most Popular

Latest Events

WESTVET
Tue May 14, 2019 @ 8:00am - 05:00pm
BC Poultry Symposium
Wed May 15, 2019 @ 8:00am - 05:00pm
Platinum Brooding Course
Thu May 23, 2019 @ 9:45am - 03:00pm

We are using cookies to give you the best experience on our website. By continuing to use the site, you agree to the use of cookies. To find out more, read our Privacy Policy.